Table 2 Novel antigens identified in brain cancer suitable for mRNA vaccine
From: Advancing personalized medicine in brain cancer: exploring the role of mRNA vaccines
Brain cancer | Antigens | Reference |
|---|---|---|
Low grade glioma (LGG) | FCGBP, FLNC, TLR7, CSF2RA | [84] |
PTBP1, SLC39A1 | [86] | |
Diffuse glioma | KDR, COL1A2, SAMD9 | [87] |
GBM and glioma | ARPC1B, HK3 | [85] |
MMP9, SLC16A3 | [86] | |
TP53, IDH1, C3, TCF12 | [88] | |
ANXA5, FKBP10, MSN, PYGL | [89] | |
LRP1, TCF12, DERL3, WIPI2, TSHZ3 | [90] | |
ADAMTSL4, COL6A1, CTSL, CYTH4, EGFLAM, LILRB2, MPZL2, SAA2, and LSP1 | [92] | |
NAT1, FRRS1, GTF2H2C, BRCA2, GRAP, NR5A2, ABCB4, ZNF90, ERCC6L, ZNF813, and IS1/2A/2B | [93] | |
ARHGAP9, ARHGAP30, CLEC7A, MAN2B1, ARPC1B and PLB1 | [94] |